{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:26:45Z","timestamp":1771230405491,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"crossref","award":["2019-YF09-00034-CG"],"award-info":[{"award-number":["2019-YF09-00034-CG"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>To examine the association of fetal fraction with a wide spectrum of pregnancy-related complications among Chinese population, we carried out a single-institution retrospective cohort study of women with negative Noninvasive prenatal testing (NIPT) results and singleton pregnancies between May 2018 and May 2020. Indicators of pregnancy-related complications were examined individually, including preterm birth, low birth weight, hypertensive disorders of pregnancy, gestational diabetes, oligohydramnios and intrahepatic cholestasis. We evaluated disease odds ratios (ORs) and 95% confidence intervals (CIs), after controlling for potential confounders including body mass index (BMI), maternal age and gestational week at NIPT. A total of 3534 women were included in our analyses. Women with fetal fraction&lt;15.15% had increased risk of gestational hypertension (OR 4.41, CI [1.65, 12.45]) and oligohydramnios (OR 2.26, CI [1.33, 3.80]) compared to women with fetal fraction\u226515.15%. No significant associations with fetal fraction were found for preterm birth, low birth weight, gestational diabetes, and intrahepatic cholestasis. In Summary, fetal fraction is inversely associated with the risk of gestational hypertension and oligohydramnios.<\/jats:p>","DOI":"10.1371\/journal.pone.0271219","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T17:25:18Z","timestamp":1657646718000},"page":"e0271219","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["The association between fetal fraction and pregnancy-related complications among Chinese population"],"prefix":"10.1371","volume":"17","author":[{"given":"Yan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"pone.0271219.ref001","first-page":"1489","article-title":"The morbidity and mortality of pregnancy Still risky business","volume":"170","author":"DA Grimes","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0271219.ref002","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"EA Steegers","year":"2010","journal-title":"The Lancet"},{"key":"pone.0271219.ref003","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1038\/s41598-020-68842-1","article-title":"Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction","volume":"10","author":"DW Kwak","year":"2020","journal-title":"Sci Rep"},{"key":"pone.0271219.ref004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","article-title":"Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective","volume":"16","author":"Y Zhu","year":"2016","journal-title":"Curr Diab Rep"},{"key":"pone.0271219.ref005","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/pd.4952","article-title":"Cell-free DNA is higher and more fragmented in intrahepatic cholestasis of pregnancy: Intrahepatic cholestasis of pregnancy and cell-free DNA","volume":"36","author":"B Vlkov\u00e1","year":"2016","journal-title":"Prenat Diagn"},{"key":"pone.0271219.ref006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3399\/bjgp17X691625","article-title":"Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening","volume":"67","author":"I Rafi","year":"2017","journal-title":"Br J Gen Pract"},{"key":"pone.0271219.ref007","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: Cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"35","author":"ES Taglauer","year":"2014","journal-title":"Placenta"},{"key":"pone.0271219.ref008","doi-asserted-by":"crossref","first-page":"a023085","DOI":"10.1101\/cshperspect.a023085","article-title":"Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA","volume":"5","author":"LS Chitty","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"pone.0271219.ref009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0038-1667374","article-title":"Association of Fetal Fraction of Cell-Free DNA and Hypertensive Disorders of Pregnancy","volume":"36","author":"W Bender","year":"2019","journal-title":"Am J Perinatol"},{"key":"pone.0271219.ref010","doi-asserted-by":"crossref","first-page":"008","DOI":"10.1055\/s-0039-1694005","article-title":"High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes","volume":"37","author":"LL Shook","year":"2020","journal-title":"Am J Perinatol"},{"key":"pone.0271219.ref011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","article-title":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","volume":"16","author":"KD Gerson","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"pone.0271219.ref012","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pd.4779","article-title":"Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing: Low fetal fraction and perinatal outcomes","volume":"36","author":"I Krishna","year":"2016","journal-title":"Prenat Diagn"},{"key":"pone.0271219.ref013","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejogrb.2018.03.048","article-title":"Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy","volume":"224","author":"N Suzumori","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"pone.0271219.ref014","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pd.5671","article-title":"Association between cell\u2010free DNA fetal fraction and gestational diabetes","volume":"40","author":"MK Hopkins","year":"2020","journal-title":"Prenat Diagn"},{"key":"pone.0271219.ref015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajog.2016.02.009","article-title":"Cell-free DNA fetal fraction and preterm birth","volume":"215","author":"L Dugoff","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0271219.ref016","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/1566524016666161013142335","article-title":"Clinical Experience of Non-Invasive Prenatal Chromosomal Aneuploidy Testing in 190,277 Patient Samples","volume":"16","author":"H Hu","year":"2016","journal-title":"Curr Mol Med"},{"key":"pone.0271219.ref017","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.1518151112","article-title":"Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA","volume":"112","author":"A Yin","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0271219.ref018","first-page":"1865","article-title":"Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy","volume":"31","author":"FP Scott","year":"2018","journal-title":"J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"pone.0271219.ref019","doi-asserted-by":"crossref","first-page":"812781","DOI":"10.3389\/fped.2022.812781","article-title":"Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review","volume":"10","author":"C Deng","year":"2022","journal-title":"Front Pediatr"},{"key":"pone.0271219.ref020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12978-020-0854-y","article-title":"Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries","volume":"17","author":"L Figueroa","year":"2020","journal-title":"Reprod Health"},{"key":"pone.0271219.ref021","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1469-0705.2001.00570.x","article-title":"Oligohydramnios: use and misuse in clinical management: Editorial","volume":"18","author":"DM Sherer","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"pone.0271219.ref022","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000444524","article-title":"Early Prediction of Hypertensive Disorders of Pregnancy Using Cell-Free Fetal DNA, Cell-Free Total DNA, and Biochemical Markers","volume":"40","author":"SY Kim","year":"2016","journal-title":"Fetal Diagn Ther"},{"key":"pone.0271219.ref023","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/pd.4940","article-title":"Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes: Cell-free DNA levels and pregnancy outcomes","volume":"36","author":"Page-Christiaens GCML","year":"2016","journal-title":"Prenat Diagn"},{"key":"pone.0271219.ref024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0035-1570383","article-title":"Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia","volume":"34","author":"R Silver","year":"2016","journal-title":"Am J Perinatol"},{"key":"pone.0271219.ref025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000346806","article-title":"Maternal plasma cell-free fetal and maternal DNA at 11\u201313 weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes","volume":"33","author":"LCY Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"pone.0271219.ref026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajog.2008.07.063","article-title":"Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction","volume":"200","author":"MS Alberry","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0271219.ref027","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.3390\/ijms14047571","article-title":"Quantification of Maternal Serum Cell-Free Fetal DNA in Early-Onset Preeclampsia","volume":"14","author":"H Yu","year":"2013","journal-title":"Int J Mol Sci"},{"key":"pone.0271219.ref028","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ajh\/hpx024","article-title":"Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome","volume":"30","author":"R Mu\u00f1oz-Hern\u00e1ndez","year":"2017","journal-title":"Am J Hypertens"},{"key":"pone.0271219.ref029","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00428-017-2239-3","article-title":"Placental pathology varies in hypertensive conditions of pregnancy","volume":"472","author":"J. Stanek","year":"2018","journal-title":"Virchows Arch Int J Pathol"},{"key":"pone.0271219.ref030","first-page":"178","article-title":"The role of apoptosis in preeclampsia","volume":"7","author":"R. Levy","year":"2005","journal-title":"Isr Med Assoc J IMAJ"},{"key":"pone.0271219.ref031","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/jhh.2013.148","article-title":"Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China","volume":"28","author":"J Xiao","year":"2014","journal-title":"J Hum Hypertens"},{"key":"pone.0271219.ref032","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1016\/j.ajog.2021.11.1025","article-title":"Racial and Ethnic Inequities in Pre-eclampsia Management","volume":"226","author":"GL Wilkie","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0271219.ref033","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pd.3917","article-title":"High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery","volume":"32","author":"TR Jakobsen","year":"2012","journal-title":"Prenat Diagn"},{"key":"pone.0271219.ref034","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/REP-17-0619","article-title":"Cell-free fetal DNA and spontaneous preterm birth","volume":"155","author":"SR van Boeckel","year":"2018","journal-title":"Reproduction"},{"key":"pone.0271219.ref035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.placenta.2020.02.016","article-title":"Inflammation-mediated generation and inflammatory potential of human placental cell-free fetal DNA","volume":"93","author":"SR van Boeckel","year":"2020","journal-title":"Placenta"},{"key":"pone.0271219.ref036","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s43032-019-00023-6","article-title":"Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births","volume":"27","author":"N Gomez-Lopez","year":"2020","journal-title":"Reprod Sci"},{"key":"pone.0271219.ref037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1471-0528.14197","article-title":"Debates on fetal fraction measurement and DNA-based noninvasive prenatal screening: time for standardisation?","volume":"123","author":"T Wataganara","year":"2016","journal-title":"BJOG Int J Obstet Gynaecol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T13:47:02Z","timestamp":1700833622000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271219"}},"subtitle":[],"editor":[{"given":"Badri","family":"Padhukasahasram","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0271219","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}